Highbridge Capital Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Highbridge Capital Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	–	–	404
2023 Q1	–	Hold	0	–	–	–	386
2022 Q4	–	Hold	0	–	–	–	357
2022 Q3	–	Hold	0	–	–	–	370
2022 Q2	–	Hold	0	–	–	–	377
2022 Q1	–	Hold	0	–	–	–	351
2021 Q4	–	Hold	0	–	–	–	403
2021 Q3	–	Hold	0	–	–	–	266

Other funds holding STLNW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return